Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. PTC Therapeutics Inc shares valued at $44,034 were sold by Utter Christine Marie on Feb 19 ’25. At $50.10 per share, Utter Christine Marie sold 879 shares. The insider’s holdings dropped to 63,442 shares worth approximately $3.21 million following the completion of this transaction.
Also, Utter Christine Marie sold 878 shares, netting a total of over 44,009 in proceeds. Following the sale of shares at $50.12 each, the insider now holds 62,564 shares.
Before that, Gravier Pierre had sold 1,168 shares from its account. In a trade valued at $58,512, the CHIEF FINANCIAL OFFICER traded PTC Therapeutics Inc shares for $50.10 each. Upon closing the transaction, the insider’s holdings decreased to 1,168 shares, worth approximately $3.82 million.
As published in a research note from Morgan Stanley on December 13, 2024, PTC Therapeutics Inc [PTCT] has been rated up from an Equal-weight to an Overweight and the price target has been revised to $67 from $45. Analysts at RBC Capital Mkts upgraded the stock from ‘”a Sector perform”‘ to ‘”an Outperform”‘ outlook in a report released in early December. Earlier on September 04, 2024, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for PTCT stock.
Analyzing PTCT Stock Performance
During the last five days, there has been a surge of approximately 0.38%. Over the course of the year, PTC Therapeutics Inc shares have jumped approximately 12.03%. Shares of the company reached a 52-week high of $52.95 on 02/18/25 and a 52-week low of $41.67 on 01/14/25. A 50-day SMA is recorded $47.01, while a 200-day SMA reached $39.48. Nevertheless, trading volume fell to 0.92 million shares from 0.48 million shares the previous day.
Support And Resistance Levels for PTC Therapeutics Inc (PTCT)
According to the 24-hour chart, there is a support level at 49.83, which, if violated, would cause prices to drop to 49.08. In the upper region, resistance lies at 51.96. The next price resistance is at 53.34. RSI (Relative Strength Index) is 58.34 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.55, which suggests the price will decrease in the coming days. Percent R is at 41.83%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
